Portfolio momentum USVP has a long track record since 1981, investing $4.3 billion across 523 companies with multiple exits, indicating a strong deal flow and robust network that can be tapped for co-investments, syndication, or later-stage opportunities.

Sector focus Active emphasis on enterprise software, cyber security, healthcare IT enabled services, and consumer/e-commerce suggests targeting these verticals for partnerships, portfolio referrals, and potential co-creation of solutions with USVP-backed ventures.

Recent activity Recent investments in Maneva, Mealogic, Nervonik, Okami Medical, Stream, Cagent Vascular and IONIX show ongoing appetite for AI, manufacturing intelligence, digital health and security—excellent openings for collaboration or strategic pilots.

Fundraising status Currently investing from USVP XIII signals continued capital availability and readiness for new rounds, non-dilutive collaboration opportunities, co-led financings, and strategic partnerships with early growth-stage startups.

Network leverage The team combines veteran investors, former CEOs, and founders with a hands-on coaching approach, creating opportunities for executive-level introductions, strategic advisement partnerships, and accelerated revenue trajectories for portfolio companies.